Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)

Q: When is the deadline for Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)?

This is a forecast opportunity; the agency has not posted dates yet.

Q: Who is eligible for Ancillary Studies to Ongoing Clinical Projects (RP1 Clinical Trial Not Allowed)?

Eligible applicants: Tribal organizations; School districts; Private colleges & universities; Nonprofits (501(c)(3)); County governments; Public & Indian housing authorities; For-profit businesses; State governments.

National Institutes of Health

Federal Grants for Science Research

Funding Amount

$2,000,000 total

Deadline

Forecast — dates not yet posted

Grant Type

Federal

Can we apply?

Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.

Eligible organizations

Tribal organizations
School districts
Private colleges & universities
Nonprofits (501(c)(3))
County governments
Public & Indian housing authorities
For-profit businesses
State governments

Overview

Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on ancillary studies that aim to leverage the resources from the ongoing parent clinical studies such as well-characterized patient cohort(s), infrastructure, data, and biological samples. While parent studies can be outside the NIAMS mission, this ancillary study should meet the NIAMS mission. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Investigators with expertise and insights into diseases and conditions within the NIAMS mission are encouraged to begin to consider applying to this NOFO. In addition, collaborative investigations combining expertise in leveraging clinical research will be encouraged, and these investigators should also begin considering applying.